Tau epitope display in progressive supranuclear palsy and corticobasal degeneration.

Filamentous aggregates of the protein tau are a prominent feature of Alzheimer's disease (AD), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). However, the extent to which the molecular structure of the tau in these aggregates is similar or differs between these diseases is unclear. We approached this question by examining these disorders with a panel of antibodies that represent different structural, conformational, and cleavage-specific tau epitopes. Although each of these antibodies reveals AD pathology, they resolved into three classes with respect to PSP and CBD: AD2 and Tau-46.1 stained the most tau pathology in all cases; Tau-1, 2, 5, and 12 exhibited variable reactivity; and Tau-66 and MN423 did not reveal any tau pathology. In addition, hippocampal neurofibrillary tangles in these cases showed a predominantly PSP/CBD-like, rather than AD-like, staining pattern. These results indicate that the patterns of the tau epitopes represented by this panel that reside in the pathological aggregates of PSP and CBD are similar to each other but distinct from that of AD.

A mathematical model of haemopoiesis as exemplified by CD34 cell mobilization into the peripheral blood.

A mathematical model for the kinetics of haemopoietic cells, including CD34+cells, is proposed. This minimal model reflects the known kinetics of haemopoietic progenitor cells, including peripheral blood CD34+ cells, white blood cells and platelets, in the presence of granulocyte colony-stimulating factor. Reproducing known perturbations within this system, subjected to granulocyte colony-stimulating factor treatment and apheresis of peripheral blood progenitor cells (CD34+ cells) in healthy individuals allows validation of the model. Predictions are made with this model for reducing the length of time with neutropenia after high-dose chemotherapy. Results based on this model indicate that myelosuppressive treatment together with infusion of CD34+ peripheral blood progenitor cells favours a faster recovery of the haemopoietic system than with granulocyte colony-stimulating factor alone. Additionally, it predicts that infusion of white blood cells and platelets can relieve the symptoms of neutropenia and thrombocytopenia, respectively, without drastically hindering the haemopoietic recovery period after high dose chemotherapy.

Aging, spatial learning, and total synapse number in the rat CA1 stratum radiatum.

The aim of this study was to determine whether spatial learning deficits in aged rats are associated with a loss of hippocampal synapses. The Morris water maze task was used to assess the spatial learning capacity of young and aged rats and to attribute aged animals to learning-impaired and learning-unimpaired groups. The number of axospinous synapses in the entire volume of the CA1 stratum radiatum was estimated with unbiased stereological techniques. The results show that the total number of all axospinous synapses and of their perforated and nonperforated subtypes remains constant in the CA1 stratum radiatum of aged learning-impaired rats as compared to aged learning-unimpaired rats and to young adults. Thus, neither age-related deficits in spatial learning nor advanced chronological age are associated with a loss of axospinous synapses from the rat CA1 stratum radiatum.

Synapses with a segmented, completely partitioned postsynaptic density express more AMPA receptors than other axospinous synaptic junctions.

Axospinous perforated synapses of one morphological subtype exhibit multiple transmission zones, each one being formed by an axon terminal protrusion apposing a postsynaptic density (PSD) segment and separated from others by complete spine partitions. Such segmented, completely partitioned (SCP) synapses have been implicated in synaptic plasticity and postulated to be exceptionally efficacious. The present study explored the validity of this supposition. Postembedding immunogold electron microscopy was used for quantifying the postsynaptic AMPA receptor (AMPAR) expression, which is widely regarded as a major determinant of synaptic efficacy. Various subtypes of axospinous synapses were examined in the rat CA1 stratum radiatum. The results showed that the number of immunogold particles for AMPARs in SCP synapses markedly and significantly exceeded that in other perforated subtypes (by 101% on the average) and in nonperforated immunopositive synapses (by 1086%). Moreover, the particle number per single PSD segment, each of which also contained NMDA receptors, was significantly higher than that per nonperforated PSD (by 485%). SCP synapses also exhibited a higher particle density per unit PSD area, as well as a larger overall PSD area as compared with other synaptic subtypes. Analysis of covariance revealed that the high AMPAR expression in SCP synapses was related to the segmented PSD configuration, not only to the PSD size. Moreover, the subpopulations of SCP and other perforated synapses with either overlapping or equal PSD sizes differed in AMPAR content and concentration, with both measures being significantly higher in SCP synapses. Thus, the elevated AMPAR expression in SCP synapses is associated with the presence of separate PSD segments, not only with their large PSD area. These findings are consistent with the idea that SCP synapses have a relatively greater efficacy and may support maximal levels of synaptic enhancement characteristic of certain forms of synaptic plasticity such as the early LTP phase.

Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment.

Abnormal aggregation of the microtubule-associated protein, tau, occurs in many neurodegenerative diseases, making it important to understand the mechanisms of tau polymerization. Previous work has indicated that the C-terminal region of tau inhibits polymerization in vitro, and a growing body of evidence implicates caspase cleavage of tau at Asp 421 in the C-terminus as an important inducer of tau polymerization in Alzheimer's disease. In the present study, we provide evidence that the C-terminal peptide fragment produced by caspase cleavage inhibits tau polymerization, suggesting that caspase cleavage of tau enhances its polymerization by removing the inhibitory control element. Moreover, we provide evidence that the peptide assumes an alpha-helical configuration and inhibits tau assembly by interacting with residues 321-375 in the microtubule binding repeat region. These findings indicate that formation of the fibrillar pathologies during the course of Alzheimer's disease may be driven or sustained by apoptotic events leading to caspase activation.

Pathological glial tau accumulations in neurodegenerative disease: review and case report.

Abnormal deposits of tau protein accumulate in glia in many neurodegenerative diseases. This suggests that in some instances the disease process may target glial tau, with neuronal degeneration a secondary consequence of this process. In this report, we summarize the pattern of glial tau pathology in various neurodegenerative disorders and add original findings from a case of sporadic frontotemporal dementia that exhibits astrocytic tau pathology. The neurodegenerative diseases span the spectrum of relative neuronal and glial tau involvement, from disorders affecting only neuronal tau to those in which abnormal tau deposits are found only in glia. From this, we conclude that glial tau can be a primary target of the disease process, and that this can lead to neuronal degeneration.

Associative learning elicits the formation of multiple-synapse boutons.

The formation of new synapses has been suggested to underlie learning and memory. However, previous work from this laboratory has demonstrated that hippocampus-dependent associative learning does not induce a net gain in the total number of hippocampal synapses and, hence, a net synaptogenesis. The aim of the present work was to determine whether associative learning involves a specific synaptogenesis confined to the formation of multiple-synapse boutons (MSBs) that synapse with more than one dendritic spine. We used the behavioral paradigm of trace eyeblink conditioning, which is a hippocampus-dependent form of associative learning. Conditioned rabbits were given daily 80-trial sessions to a criterion of 80% conditioned responses in a session. During each trial, the conditioned stimulus (tone) and the unconditioned stimulus (corneal airpuff) were presented with an intervening trace interval of 500 msec. Brain tissue was taken for morphological analyses 24 hr after the last session. Unbiased stereological methods were used for obtaining estimates of the total number of MSBs in the stratum radiatum of hippocampal subfield CA1. The results showed that the total number of MSBs was significantly increased in conditioned rabbits as compared with pseudoconditioned or unstimulated controls. This conditioning-induced change, which occurs without a net synaptogenesis, reflects a specific synaptogenesis resulting in MSB formation. Models of the latter process are proposed. The models postulate that it requires spine motility and may involve the relocation of existing spines from nonactivated boutons or the outgrowth of newly formed spines for specific synaptogenesis with single-synapse boutons activated by the conditioning stimulation.

Tau-66: evidence for a novel tau conformation in Alzheimer's disease.

We have characterized a novel monoclonal antibody, Tau-66, raised against recombinant human tau. Immunohistochemistry using Tau-66 reveals a somatic-neuronal stain in the superior temporal gyrus (STG) that is more intense in Alzheimer's disease (AD) brain than in normal brain. In hippocampus, Tau-66 yields a pattern similar to STG, except that neurofibrillary lesions are preferentially stained if present. In mild AD cases, Tau-66 stains plaques lacking obvious dystrophic neurites (termed herein 'diffuse reticulated plaques') in STG and the hippocampus. Enzyme-linked immunosorbent assay (ELISA) analysis reveals that Tau-66 is specific for tau, as there is no cross-reactivity with MAP2, tubulin, Abeta(1-40), or Abeta(1-42), although Tau-66 fails to react with tau or any other polypeptide on western blots. The epitope of Tau-66, as assessed by ELISA testing of tau deletion mutants, appears discontinuous, requiring residues 155-244 and 305-314. Tau-66 reactivity exhibits buffer and temperature sensitivity in an ELISA format and is readily abolished by SDS treatment. Taken together these lines of evidence indicate that the Tau-66 epitope is conformation-dependent, perhaps involving a close interaction of the proline-rich and the third microtubule-binding regions. This is the first indication that tau can undergo this novel folding event and that this conformation of tau is involved in AD pathology.

Oxidative regulation of fatty acid-induced tau polymerization.

Alzheimer's disease (AD) is characterized by the presence of amyloid-positive senile plaques and tau-positive neurofibrillary tangles. Aside from these two pathological hallmarks, a growing body of evidence indicates that the amount of oxidative alteration of vulnerable molecules such as proteins, DNA, and fatty acids is elevated in the brains of AD patients. It has been hypothesized that the elevated amounts of protein oxidation could lead directly to the formation of neurofibrillary tangles through a cysteine-dependent mechanism. We have tested this hypothesis in an in vitro system in which tau assembly is induced by fatty acids. Using sulfhydryl protective agents and site-directed mutagenesis, we found that cysteine-dependent oxidation of the tau molecule is not required for its polymerization and may even be inhibitory. However, by adjusting the oxidative environment of the polymerization reaction through the addition of a strong antioxidant or through the addition of an oxidizing system consisting of iron, adenosine diphosphate, and ascorbate, we found that oxidation does play a major role in our in vitro paradigm. The results indicated that fatty acid oxidation, the amount of which is found to be elevated in AD patients, can facilitate the polymerization of tau. However, "overoxidation" of the fatty acids can inhibit the process. Therefore, we postulate that specific fatty acid oxidative products could provide a direct link between oxidative stress mechanisms and the formation of neurofibrillary tangles in AD.

C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease.

Alzheimer's disease (AD) is, in part, defined by the polymerization of tau into paired helical and straight filaments (PHF/SFs) which together comprise the fibrillar pathology in degenerating brain regions. Much of the tau in these filaments is modified by phosphorylation. Additionally, a subset also appears to be proteolytically truncated, resulting in the removal of its C terminus. Antibodies that recognize tau phosphorylated at S(396/404 )or truncated at E(391) do not stain control brains but do stain brain sections very early in the disease process. We modeled these phosphorylation and truncation events by creating pseudo-phosphorylation and deletion mutants derived from a full-length recombinant human tau protein isoform (ht40) that contains N-terminal exons 2 and 3 and all four microtubule-binding repeats. In vitro assembly experiments demonstrate that both modifications greatly enhance the rates of tau filament formation and that truncation increases the mass of polymer formed, as well. Removal of as few as 12 or as many as 121 amino acids from the C terminus of tau greatly increases the rate and extent of tau polymerization. However, deletion of an additional 7 amino acids, (314)DLSKVTS(320), from the third microtubule-binding repeat results in the loss of tau's ability to form filaments in vitro. These results suggest that only part of the microtubule-binding domain (repeats 1, 2 and a small portion of 3) is crucial for tau polymerization. Moreover, the C terminus of tau clearly inhibits the assembly process; this inhibition can be partially reversed by site-specific phosphorylation and completely removed by truncation events at various sites from S(320) to the end of the molecule.

In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants.

Tau polymerization into the filaments that compose neurofibrillary tangles is seminal to the development of many neurodegenerative diseases. It is therefore important to understand the mechanisms involved in this process. However, a consensus method for monitoring tau polymerization in vitro has been lacking. Here we demonstrate that illuminating tau polymerization reactions with laser light and measuring the increased scattering at 90 degrees to the incident beam with a digital camera results in data that closely approximate the mass of tau polymer formation in vitro. The validity of the technique was demonstrated over a range of tau concentrations and through multiple angle scattering measurements. In addition, laser light scattering data closely correlated with quantitative electron microscopy measurements of the mass of tau filaments. Laser light scattering was then used to measure the efficiency with which the mutant tau proteins found in frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17) form filamentous structures. Several of these mutant proteins display enhanced polymerization in the presence of arachidonic acid, suggesting a direct role for these mutations in tau the filament formation that characterizes FTDP-17.

Determinants of potency and temperature-dependent function in the Aplysia bag cell peptides.

Structure-activity relationships were determined for the natural bag cell peptides (BCPs) and for a series of synthetic analogues in terms of their ability to stimulate (at 30 degrees C) and to inhibit (at 15 degrees C) bag cell adenyl cyclase. We found that the core RLRF motif shared by all these peptides is active in this assay, and is stimulatory. The histidine residue C-terminal to this motif in beta-BCP is superfluous in this respect. An electronegative residue C-terminal to RLRF is sufficient to induce temperature-dependent function. The Ala-Pro pair that is N-terminal to this motif in alpha-BCP increases potency, but does not alter function.

Temperature-dependent stimulation and inhibition of adenylate cyclase by Aplysia bag cell peptides.

The bag cell peptides (alpha-, beta-, and gamma-BCP) are secreted by the neuroendocrine bag cells of Aplysia, and provide feedback modulation of bag cell excitability and cAMP levels. We report here that if 200-500 mM NaCl is included in the assay buffer, the BCPs alter adenylate cyclase activity in a manner consistent with their effects on cAMP levels in intact bag cells. Specifically, beta-BCP and the related peptide A from the atrial gland stimulate the enzyme, while the effects of alpha-BCP(1-7) and gamma-BCP are temperature-dependent, stimulating at 30 degrees C and inhibiting at 15 degrees C. Both stimulation and inhibition require GTP, suggesting mediation by Gs and Gi. The ionic requirements of stimulation and inhibition differ: Cl- is necessary to support stimulation, but not inhibition. Moreover, pertussis toxin blocks inhibition, but does not affect stimulation. These results suggest that the temperature-sensitive mechanism lies upstream from the G-proteins in the signal transduction pathway.

ProELH-related peptides: influence on bag cell cAMP levels.

ProELH is the prohormone to the bag cell egg-laying peptide of Aplysia. In addition to containing the structure of the hormone (ELH) itself, proELH also contains several other secreted peptides: AP (acidic peptide) and alpha-, beta-, and gamma-bag cell peptides (BCPs). The BCPs, ranging in length from 5 to 9 amino acids, are structurally similar in that they all contain the sequence Arg-Leu-Arg-Phe. An additional peptide from the atrial gland, Atrial A, also contains this sequence. The BCPs previously have been reported to have direct feedback (autocrine) effects on the bag cells, including electrophysiological excitation and inhibition. Moreover, some of these effects are temperature-dependent. The autocrine functions of these peptides were explored here by investigating their effects on bag cell cAMP levels. In addition, we monitored the effects of Atrial A, as well as ELH and AP, which are proELH products that do not have sequence homology with the BCPs. While ELH and AP have no effect on bag cell cAMP levels, the other peptides fall into two functional classes. alpha- and gamma-BCP produce an elevation of cAMP levels at 20 degrees and a depression at 15 degrees C. The elevation in cAMP is sensitive to low Ca2+/high Mg2+. beta-BCP and Atrial A elevate cAMP levels independently of temperature, and are insensitive to low Ca2+/high Mg2+. Our results suggest that there may be multiple bag cell receptors for these peptides with the Arg-Leu-Arg-Phe sequence representing a receptor-recognition motif.

Temperature-dependent peptidergic feedback: potential role in seasonal egg laying in Aplysia.

alpha-Bag cell peptide (alpha-BCP), one of the secretory products of the neuroendocrine bag cells in Aplysia, has been reported by various investigators to have either excitatory or inhibitory feedback effects. Though conflicting, these results may be explained by the difference in temperature at which the experiments were performed. Because egg laying in this animal is temperature dependent, the alteration in function of this peptide by temperature may offer a possible molecular basis for the seasonal regulation of egg laying. This hypothesis was investigated by assessing the feedback actions of alpha-BCP at various temperatures. At 15 degrees C, alpha-BCP hyperpolarized bag cells, shortened the duration of synaptically evoked bag cell discharges, and reduced the number of action potentials per discharge. However, at 20 degrees C, the peptide depolarized bag cells, lengthened discharges, and increased the number of action potentials per discharge. A temperature-dependent influence on bag cell cAMP levels may underlie these effects, because alpha-BCP reduced basal cAMP levels in intact bag cells at temperatures of 15 degrees C and below, while at 17-22 degrees C it increased these levels. However, the inhibitory effects of alpha-BCP on stimulated adenylate cyclase activity in bag cell homogenates were not temperature dependent. Moreover, a low-Ca2+/high-Mg2+ solution abolished alpha-BCP's ability to increase bag cell cAMP levels at 20 degrees C. This suggests that the peptide may evoke the secretion of an excitatory modulator at the higher temperature. These results imply that alpha-BCP is autoinhibitory at typical winter temperatures, but becomes autoexcitatory as ocean temperature rises in the summer. Thus, the peptide may function in coordination with other factors to regulate egg laying in response to seasonal temperature variations.

Alpha-bag cell peptide inhibits bag cell adenylate cyclase via a GTP-dependent mechanism.

alpha-Bag cell peptide (alpha-BCP), one of several secreted peptides encoded in the precursor to the egg-laying hormone (proELH) of the neurosecretory bag cells of Aplysia, has been variously reported to have autoexcitatory or autoinhibitory effects on the cells which secrete it. Since we had found previously that alpha-BCP reduces stimulated cAMP levels in intact bag cells, an effect that would be consistent with electrophysiological inhibition, we investigated the direct effect of the peptide on adenylate cyclase in bag cell membrane preparations. alpha-Bag cell peptide did not affect basal adenylate cyclase activity, but reduced forskolin-stimulated activity by about 30%. The potency of the peptide in this assay was within the range reported for observable physiological effects: half-maximal inhibition was seen at approximately 100 nM peptide. Both basal and forskolin-stimulated enzyme activity were dependent on GTP, and the inhibitory effect of alpha-BCP was inversely dependent on the nucleotide. The non-hydrolyzable analogue, GTP-gamma-S, stimulated both basal and forskolin-stimulated enzyme activity and enhanced alpha-BCP's effect to the extent that the peptide completely inhibited forskolin's stimulation of the enzyme. The peptide's effect could be blocked by pretreatment with pertussis toxin. We conclude that alpha-BCP inhibits bag cell adenylate cyclase, an effect which is consistent with an autoinhibitory role in bag cell function. Moreover, this inhibition appears to be mediated by a GTP-binding protein.

Molecular and cellular regulation of neuropeptide expression: the bag cell model system.

The bag cell neuroendocrine system of Aplysia californica has been under intensive investigation for nearly two decades. The favorable morphology and hardiness in organ culture of this preparation have permitted a wide range of electrophysiological, cellular, and molecular studies. In this review we have focused our attention on the biochemical and physiological processes that serve the principle function of the bag cells: the synthesis and secretion of the neuropeptide egg-laying hormone. Although these cells were at first considered a model system for the most elementary neuroendocrine mechanisms, increasing knowledge has disclosed a surprising degree of complexity in both neuropeptide biosynthesis and the electrophysiological processes responsible for secretion. Not only may various components of the prohormone be sorted into different classes of neurosecretory granules, which may in turn have different probabilities of secretion, but biosynthesis itself appears to be regulated by the same intracellular messengers that mediate the electrophysiological discharge cycle. Hence, the bag cells, and presumably other peptidergic neurons, appear to possess an array of regulatory processes that can modulate the amount and character of their secretory output. The interactions of these processes may confer a degree of plasticity to the functional expression of peptidergic neurons unanticipated in studies of other neuron types.

Alpha bag cell peptide reduces stimulated cAMP levels and pro-ELH synthesis in bag cells.

alpha-Bag cell peptide (alpha-BCP), one of the multiple secretory products of the precursor to the egg-laying hormone (proELH) produced by the neurosecretory bag cells of Aplysia, has been variously claimed to have excitatory or inhibitory feedback effects on the cells which secrete it and to exert some of these effects via a reduction in cAMP levels. Since it was shown previously that proELH synthesis is modulated by cAMP, the present study was undertaken to determine if alpha-BCP causes parallel alterations in cAMP levels and peptide synthesis. The peptide had no effect on bag cell levels of cAMP in the absence of stimulation and no effect on the elevation of this nucleotide by the phosphodiesterase inhibitor, isobutylmethylxanthine. However, it reduced the elevations induced by forskolin, dopamine, and high external potassium. Consistent with the above and with the hypothesis that proELH synthesis is accelerated by cAMP, alpha-BCP reduced proELH synthesis and cAMP production in parallel in forskolin-stimulated preparations, but did not inhibit stimulation of peptide synthesis by isobutylmethylxanthine or zero external Ca2+. These results support an autoinhibitory role for alpha-BCP in modulating bag cell discharge and suggest a mechanism by which it can mediate negative feedback inhibition of proELH biosynthesis.

Calcium and protein kinase C inhibit biosynthesis of Aplysia egg-laying hormone.

Previous studies on the biosynthesis of the peptide egg-laying hormone (ELH) of Aplysia have suggested that the increase in cAMP levels associated with the initiation of a bag cell discharge stimulated ELH synthesis, whereas the calcium influx associated with the discharge inhibits it. This report provides additional documentation of the inhibitory role of calcium. Inhibition by the calcium ionophore A23187 was shown to be dependent on the presence of extracellular calcium. A23187 inhibited ELH synthesis and exposure to 0 Ca2+/2 mM EGTA medium stimulated it in bag cell somata surgically deprived of their sites of synaptic input. The tumor-promoting phorbol ester, TPA, inhibited ELH biosynthesis in a calcium-dependent fashion, whereas the non-tumor-promoting 4 alpha-phorbol did not. These results are consistent with the hypothesis that calcium entry during bag cell discharge may inhibit ELH synthesis via activation of protein kinase C, thus counteracting the stimulation by cAMP early in the discharge. Such a mechanism could precisely regulate the production of ELH molecules to replace those lost by secretion.